Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers

Journal of the National Cancer Institute

Volumn 89, Issue 12, 1997, Pages 868-873

  Prokopczyk, Bogdan ^a   Cox, Jonathan E ^a   Hoffmann, Dietrich ^a   Waggoner, Steven E ^b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE; NICOTINE DERIVATIVE;

ADULT; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CLINICAL ARTICLE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; ORAL CONTRACEPTION; PAPANICOLAOU TEST; RISK ASSESSMENT; SOCIOECONOMICS; UTERINE CERVIX CANCER; UTERINE CERVIX MUCOSA; WART VIRUS;

EID: 0030994104     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.12.868     Document Type: Article

References (43)

1. Magrath I, Litvak J. Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst 1993;85:862-74.
2. Page HS, Asire AJ. Cancer rates and risks. 3rd ed. Washington (DC): US Govt Print Off; 1985 Report No.: DHHS Publ No. (NIH)85-691.
3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46: 5-27.
4. Kosary CL, Ries LA, Miller BA, Hankey BF, Harris H, Edwards BK, editors. SEER cancer statistics review 1973-1992. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1995 Report No.: DHHS Publ No. (NIH)95-2789.
5. Wingo PA, Bolden S, Tong T, Parker SL, Martin ML, Heath CW Jr. Cancer statistics for African Americans, 1996 [published erratum appears in CA Cancer J Clin 1996;46:164]. CA Cancer J Clin 1996;46:113-25.
6. International Agency for Research on Cancer. Human papillomavirus. IARC Monogr Eval Carcinog Risk Hum 64:1995.
7. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85: 958-64.
8. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
9. Schneider A, Shah K. The role of vitamins in the etiology of cervical neoplasia: an epidemiological review. Arch Gynecol Obstet 1989;246: 1-13.
10. Basu J, Palan PR, Vermund SH, Goldberg GL, Burk RD, Romney SL. Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia. Cancer Detect Prev 1991;15:165-70.
11. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 1993;2:335-9.
12. Baquet CR, Horm JW, Gibbs T, Greenwald P. Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 1991;83:551-7.
13. Barnhart KT, Sondheimer SJ. Contraception choice and sexually transmitted diseases. Current opinion. Obstet Gynecol 1994;5:823-8.
14. Naguib SM, Lundin FE Jr, Davis HJ. Relation of various epidemiologic factors to cervical cancer as determined by a screening program. Obstet Gynecol 1966;82:451-9.
15. U.S. Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. Washington (DC): US Department of Health and Human Services; January 11, 1989 Report No.: DHHS Publ No. (CDC)89-8411, pp 57-8.
16. Winkelstein W Jr. Smoking and cervical cancer - current status: a review. Am J Epidemiol 1990;6:945-57.
17. Greenberg ER, Vessey M, McPherson K, Yeates D. Cigarette smoking and cancer of the uterine cervix. Br J Cancer 1985;51:139-41.
18. Slattery ML, Robison LM, Schuman KL, French TK, Abbott TM, Overall JC Jr, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA 1989;261:1593-8.
19. Szarewski A, Jarvis MJ, Sasieni P, Anderson M, Edwards R, Steele SJ, et al. Effect of smoking cessation on cervical lesion size. Lancet 1996;347:941-3.
20. Sasson IM, Haley NJ, Hoffmann D, Wynder EL, Hellberg D, Nilsson S. Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus [letter]. N Engl J Med 1985;312:315-6.
21. Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD, et al. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res 1987;47:3886-8.
22. McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992;1:125-9.
23. Hoffmann D, Hoffmann I. The changing cigarette 1950-1995. J Toxicol Environ Health 1997;50:307-64.
24. Hoffmann D, Hoffmann I. Tobacco consumption and lung cancer. In: Hansen HH, editor. Lung cancer. Advances in basic and clinical research. Boston: Kluwer Academic Publ, 1995:1-42.
25. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health 1994;41:1-52.
26. Hecht SS, Jordan KG, Choi CI, Trushin N. Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis 1990;11:1017-20.
27. Prokopczyk B, Wu M, Cox JE, Amin S, Desai D, Idris AM, et al. Improved methodology for the quantitative assessment of tobacco-specific N-nitrosamines in tobacco by supercritical fluid extraction. J Agr Food Chem 1995;43: 916-22.
28. Prokopczyk B, Hoffmann D, Cox JE, Djordjevic MV, Brunnemann KD. Supercritical fluid extraction in the determination of tobacco-specific N-nitrosamines in smokeless tobacco. Chem Res Toxicol 1992;5:336-40.
29. Wagenknecht LE, Burke GL, Perkins LL, Haley NL, Freedman GD. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health 1992;82:33-6.
30. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988;9:875-84.
31. Hecht SS. Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug Metab Rev 1994;26:373-90.
32. Patel KR, Astley S, Adams DJ, Lacy CJ, Ali SW, Wells M. Expression of cytochrome P450 enzymes in the cervix. An immunohistochemical study. Int J Gynecol Cancer 1993;3:159-63.
33. Farin FM, Bigler LG, Oda D, McDougall JK, Omiecinski CJ. Expression of cytochrome P450 and microsomal epoxide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6/E7 genes [published erratum appears in Carcinogenesis 1995;16:1670]. Carcinogenesis 1995;16:1391-401.
34. Phillips DH, Hewer A, Malcolm AD, Ward P, Coleman DV. Smoking and DNA damage in cervical cells [letter]. Lancet 1990;335:417.
35. Cuzick J, Routledge MN, Jenkins D, Garner RC. DNA adducts in different tissues of smokers and non-smokers. Int J Cancer 1990;45: 673-8.
36. Simons AM, Phillips DH, Coleman DV. Damage to DNA in cervical epithelium related to smoking tobacco. BMJ 1993;306:1444-8.
37. Ali S, Astley SB, Sheldon TA, Peel KR, Wells M. Detection and measurement of DNA adducts in the cervix of smokers and nonsmokers. Int J Gynecol Cancer 1994;4:188-93.
38. Phillips DH, She MN. DNA adducts in cervical tissue of smokers and non-smokers. Mutat Res 1994;313:277-84.
39. Hoffmann D, Castonguay A, Rivenson A, Hecht SS. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine in Syrian golden hamsters. Cancer Res 1981;41:2386-93.
40. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 1988;48:6912-7.
41. Hecht SS, Morse MA, Amin S, Stoner GD, Jordan KG, Choi CI, et al. Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis 1989;10:1901-4.
42. 6-methylguanine formation in Clara cells and the induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 1990;50: 3772-80.
43. Lijinsky W, Thomas BJ, Kovatch RM. Local and systemic carcinogenic effects of alkylating carcinogens in rats treated by intravesicular administration. Jpn J Cancer Res 1991;82:980-6.